vs
Side-by-side financial comparison of IonQ, Inc. (IONQ) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.
IonQ, Inc. is the larger business by last-quarter revenue ($61.9M vs $39.6M, roughly 1.6× SBC Medical Group Holdings Inc). IonQ, Inc. runs the higher net margin — 1217.8% vs 35.9%, a 1181.9% gap on every dollar of revenue. On growth, IonQ, Inc. posted the faster year-over-year revenue change (428.5% vs -10.9%). SBC Medical Group Holdings Inc produced more free cash flow last quarter ($51.2M vs $-83.3M).
IonQ, Inc. is an American quantum computing hardware and software company headquartered in College Park, Maryland. The company develops general-purpose trapped ion quantum computers and accompanying software to generate, optimize, and execute quantum circuits.
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
IONQ vs SBC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $61.9M | $39.6M |
| Net Profit | $753.7M | $14.2M |
| Gross Margin | — | 73.1% |
| Operating Margin | -369.4% | 32.5% |
| Net Margin | 1217.8% | 35.9% |
| Revenue YoY | 428.5% | -10.9% |
| Net Profit YoY | 473.1% | 117.2% |
| EPS (diluted) | $2.60 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $61.9M | $39.6M | ||
| Q3 25 | $39.9M | $43.4M | ||
| Q2 25 | $20.7M | $43.4M | ||
| Q1 25 | — | $47.3M | ||
| Q4 24 | $11.7M | $44.4M | ||
| Q3 24 | $12.4M | $53.1M | ||
| Q2 24 | $11.4M | $53.1M | ||
| Q1 24 | — | $54.8M |
| Q4 25 | $753.7M | $14.2M | ||
| Q3 25 | $-1.1B | $12.8M | ||
| Q2 25 | $-176.8M | $2.5M | ||
| Q1 25 | — | $21.5M | ||
| Q4 24 | $-202.0M | $6.5M | ||
| Q3 24 | $-52.5M | $2.8M | ||
| Q2 24 | $-37.6M | $18.5M | ||
| Q1 24 | — | $18.8M |
| Q4 25 | — | 73.1% | ||
| Q3 25 | — | 70.6% | ||
| Q2 25 | — | 69.2% | ||
| Q1 25 | — | 79.7% | ||
| Q4 24 | — | 76.3% | ||
| Q3 24 | — | 81.5% | ||
| Q2 24 | — | 74.2% | ||
| Q1 24 | — | 72.1% |
| Q4 25 | -369.4% | 32.5% | ||
| Q3 25 | -423.5% | 36.6% | ||
| Q2 25 | -776.0% | 33.6% | ||
| Q1 25 | — | 51.1% | ||
| Q4 24 | -661.9% | 10.6% | ||
| Q3 24 | -428.5% | 26.1% | ||
| Q2 24 | -430.0% | 51.4% | ||
| Q1 24 | — | 44.6% |
| Q4 25 | 1217.8% | 35.9% | ||
| Q3 25 | -2646.3% | 29.6% | ||
| Q2 25 | -854.5% | 5.7% | ||
| Q1 25 | — | 45.4% | ||
| Q4 24 | -1725.0% | 14.7% | ||
| Q3 24 | -423.4% | 5.3% | ||
| Q2 24 | -330.0% | 34.8% | ||
| Q1 24 | — | 34.2% |
| Q4 25 | $2.60 | $0.15 | ||
| Q3 25 | $-3.58 | $0.12 | ||
| Q2 25 | $-0.70 | $0.02 | ||
| Q1 25 | — | $0.21 | ||
| Q4 24 | $-0.95 | $0.05 | ||
| Q3 24 | $-0.24 | $0.03 | ||
| Q2 24 | $-0.18 | $0.20 | ||
| Q1 24 | — | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.4B | $164.1M |
| Total DebtLower is stronger | — | $42.8M |
| Stockholders' EquityBook value | $3.8B | $248.3M |
| Total Assets | $6.6B | $380.4M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.4B | $164.1M | ||
| Q3 25 | $1.1B | $127.4M | ||
| Q2 25 | $546.9M | $152.7M | ||
| Q1 25 | — | $132.1M | ||
| Q4 24 | $340.3M | $125.0M | ||
| Q3 24 | $365.7M | $137.4M | ||
| Q2 24 | $369.8M | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $42.8M | ||
| Q3 25 | — | $21.1M | ||
| Q2 25 | — | $7.1M | ||
| Q1 25 | — | $6.9M | ||
| Q4 24 | — | $6.6M | ||
| Q3 24 | — | $823.2K | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $3.8B | $248.3M | ||
| Q3 25 | $2.3B | $248.0M | ||
| Q2 25 | $1.2B | $244.6M | ||
| Q1 25 | — | $226.4M | ||
| Q4 24 | $383.9M | $195.1M | ||
| Q3 24 | $435.7M | $205.0M | ||
| Q2 24 | $463.3M | $8.8M | ||
| Q1 24 | — | $9.0M |
| Q4 25 | $6.6B | $380.4M | ||
| Q3 25 | $4.3B | $321.4M | ||
| Q2 25 | $1.3B | $315.3M | ||
| Q1 25 | — | $284.6M | ||
| Q4 24 | $508.4M | $266.1M | ||
| Q3 24 | $497.9M | $296.5M | ||
| Q2 24 | $517.4M | $19.5M | ||
| Q1 24 | — | $19.8M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.09× | ||
| Q2 25 | — | 0.03× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | — | 0.03× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-74.5M | $52.0M |
| Free Cash FlowOCF − Capex | $-83.3M | $51.2M |
| FCF MarginFCF / Revenue | -134.6% | 129.3% |
| Capex IntensityCapex / Revenue | 14.2% | 2.0% |
| Cash ConversionOCF / Net Profit | -0.10× | 3.66× |
| TTM Free Cash FlowTrailing 4 quarters | $-307.3M | $23.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-74.5M | $52.0M | ||
| Q3 25 | $-123.1M | $-20.9M | ||
| Q2 25 | $-52.6M | $-8.3M | ||
| Q1 25 | — | $1.9M | ||
| Q4 24 | $-39.4M | $-7.3M | ||
| Q3 24 | $-19.2M | $5.0M | ||
| Q2 24 | $-26.6M | $19.2M | ||
| Q1 24 | — | $3.7M |
| Q4 25 | $-83.3M | $51.2M | ||
| Q3 25 | $-127.2M | $-20.9M | ||
| Q2 25 | $-53.8M | $-8.6M | ||
| Q1 25 | — | $1.7M | ||
| Q4 24 | $-43.0M | $-7.9M | ||
| Q3 24 | $-23.0M | $4.6M | ||
| Q2 24 | $-34.1M | $18.3M | ||
| Q1 24 | — | $3.0M |
| Q4 25 | -134.6% | 129.3% | ||
| Q3 25 | -319.1% | -48.3% | ||
| Q2 25 | -259.8% | -19.9% | ||
| Q1 25 | — | 3.5% | ||
| Q4 24 | -367.4% | -17.8% | ||
| Q3 24 | -185.3% | 8.7% | ||
| Q2 24 | -299.3% | 34.5% | ||
| Q1 24 | — | 5.4% |
| Q4 25 | 14.2% | 2.0% | ||
| Q3 25 | 10.4% | 0.1% | ||
| Q2 25 | 5.8% | 0.7% | ||
| Q1 25 | — | 0.5% | ||
| Q4 24 | 30.7% | 1.3% | ||
| Q3 24 | 30.4% | 0.8% | ||
| Q2 24 | 65.8% | 1.6% | ||
| Q1 24 | — | 1.3% |
| Q4 25 | -0.10× | 3.66× | ||
| Q3 25 | — | -1.63× | ||
| Q2 25 | — | -3.39× | ||
| Q1 25 | — | 0.09× | ||
| Q4 24 | — | -1.12× | ||
| Q3 24 | — | 1.77× | ||
| Q2 24 | — | 1.04× | ||
| Q1 24 | — | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IONQ
| Other | $31.2M | 50% |
| Platform Consulting And Support Services | $30.7M | 50% |
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
